UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
Enhancing C. difficile vaccination in the context of TcdB-mediated immunosuppression.
Enhancing C. difficile vaccination in the context of TcdB-mediated immunosuppression. is a funding opportunity from UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, up to 337404, closing June 30, 2028.
Jun 30, 2028
(700d left)Overview
PROJECT SUMMARY (Project 1) The most recent reports indicate Clostridioides difficile is the cause of over 400,000 cases of gastrointestinal illness and nearly 30,000 deaths annually. The goals of this project are to develop an effective next generation vaccine to prevent C. difficile disease and investigate the…